FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Infinium Pharmachem IPO and Labelkraft Technologies IPO.
Infinium Pharmachem IPO is a SME Fixed Price Issue IPO proposed to list at NSE SME while Labelkraft Technologies IPO is a SME Fixed Price Issue proposed to list at BSE SME.
Infinium Pharmachem IPO | Labelkraft Technologies IPO | |
---|---|---|
Logo | ||
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Fixed Price Issue | Fixed Price Issue |
Listing At | NSE SME | BSE SME |
Lead Managers | Swastika Investmart Ltd | Hem Securities Limited |
Registrar | Bigshare Services Pvt Ltd | Bigshare Services Pvt Ltd |
Market Maker | Swastika Investmart Limited | Hem Securities Ltd. |
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | ||
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Infinium Pharmachem IPO is up to ₹25.26 Cr whereas the issue size of the Labelkraft Technologies IPO is up to ₹4.75 Cr. The final issue price of Infinium Pharmachem IPO is ₹135.00 per share and of Labelkraft Technologies IPO is ₹55.00 per share.
Infinium Pharmachem IPO | Labelkraft Technologies IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ||
Issue Price (Upper) | ||
Issue Price (Final) | ₹135.00 per share | ₹55.00 per share |
Discount (Retail) | ||
Discount (Employee) | ₹13.50 per share | |
Market Lot Size | 1000 shares | 2000 shares |
Fresh Issue Size | 18,75,000 shares | 8,64,000 shares |
Fresh Issue Size (Amount) | up to ₹25.26 Cr | up to ₹4.75 Cr |
OFS Issue Size | ||
OFS Issue Size (Amount) | ||
Issue Size Total | 18,75,000 shares | 8,64,000 shares |
Issue Size Total (Amount) | up to ₹25.26 Cr | up to ₹4.75 Cr |
Infinium Pharmachem IPO opens on Mar 31, 2023, while Labelkraft Technologies IPO opens on Mar 13, 2023. The closing date of Infinium Pharmachem IPO and Labelkraft Technologies IPO is Apr 05, 2023, and Mar 15, 2023, respectively.
Infinium Pharmachem IPO | Labelkraft Technologies IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Mar 31, 2023 | Mar 13, 2023 |
Issue Close | Apr 05, 2023 | Mar 15, 2023 |
Basis Of Allotment (Tentative) | Apr 11, 2023 | Mar 20, 2023 |
Initiation of Refunds (Tentative) | Apr 12, 2023 | Mar 21, 2023 |
Credit of Share (Tentative) | Apr 13, 2023 | Mar 22, 2023 |
Listing date (Tentative) | Apr 17, 2023 | Mar 23, 2023 |
Anchor Lockin End date 1 | May 11, 2023 | Apr 19, 2023 |
Anchor Lockin End date 2 | Jul 10, 2023 | Jun 18, 2023 |
Infinium Pharmachem IPO P/E ratio is 7.83, as compared to Labelkraft Technologies IPO P/E ratio of 62.5.
Infinium Pharmachem IPO | Labelkraft Technologies IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 100% | 99.71% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 73.05% | 73.16% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 7.83 | 62.5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹93.93 Cr. | ₹17.84 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW |
In the Infinium Pharmachem IPO retail investors (RII) are offered 9,37,500 shares while in Labelkraft Technologies IPO retail investors are offered 9,37,500 shares. Qualified institutional buyers (QIB) are offered 0 shares in Infinium Pharmachem IPO and in Labelkraft Technologies IPO.
Infinium Pharmachem IPO | Labelkraft Technologies IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | 94,000 shares | 44,000 shares |
QIB | 0 shares | |
NII | 9,37,500 shares | 4,10,000 shares |
RII | 9,37,500 shares | 4,10,000 shares |
Employee | 0 shares | |
Others | ||
Total | 18,75,000 shares | 8,20,000 shares |
Infinium Pharmachem IPO subscribed 1.84x in total, whereas Labelkraft Technologies IPO subscribed 53.42x.
Infinium Pharmachem IPO | Labelkraft Technologies IPO | |
---|---|---|
QIB (times) | ||
NII (times) | 1.80x | 46.84x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 1.86x | 59.84x |
Employee (times) | ||
Other (times) | ||
Total (times) | 1.84x | 53.42x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|